scholarly article | Q13442814 |
P2093 | author name string | Maggie A Ostrowski | |
W James Nelson | |||
Angela I M Barth | |||
Kathleen A Siemers | |||
Bertrade C Mbom | |||
P2860 | cites work | Delta-tubulin and epsilon-tubulin: two new human centrosomal tubulins reveal new aspects of centrosome structure and function | Q22011016 |
Caught Nek-ing: cilia and centrioles | Q24294508 | ||
beta-Catenin is a Nek2 substrate involved in centrosome separation | Q24303972 | ||
Conductin/axin2 and Wnt signalling regulates centrosome cohesion | Q24304045 | ||
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase | Q24306203 | ||
Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction | Q24307199 | ||
C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2 | Q24310473 | ||
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 | ||
Rootletin forms centriole-associated filaments and functions in centrosome cohesion | Q24337615 | ||
Plk1-dependent recruitment of gamma-tubulin complexes to mitotic centrosomes involves multiple PCM components | Q24338881 | ||
Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex | Q24532403 | ||
p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction | Q24551143 | ||
Re-solving the cadherin-catenin-actin conundrum | Q24609734 | ||
Nek2A kinase stimulates centrosome disjunction and is required for formation of bipolar mitotic spindles | Q24681394 | ||
Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. | Q24685871 | ||
GSK-3-selective inhibitors derived from Tyrian purple indirubins | Q27642879 | ||
Three-dimensional structure of the armadillo repeat region of beta-catenin | Q27743283 | ||
The Wnt signaling pathway in development and disease | Q27861019 | ||
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism | Q28114789 | ||
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain | Q28142613 | ||
Inhibitor-2 regulates protein phosphatase-1 complexed with NimA-related kinase to induce centrosome separation | Q28200983 | ||
Nek2 Localizes to Multiple Sites in Mitotic Cells, Suggesting Its Involvement in Multiple Cellular Functions during the Cell Cycle | Q28215182 | ||
Assembly of the cadherin-catenin complex in vitro with recombinant proteins | Q28299440 | ||
Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability | Q28585577 | ||
Convergence of Wnt, beta-catenin, and cadherin pathways | Q29619504 | ||
Adenomatous polyposis coli regulates endothelial cell migration independent of roles in beta-catenin signaling and cell-cell adhesion | Q30434502 | ||
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1 | Q30477585 | ||
The NIMA-family kinase, Nek1 affects the stability of centrosomes and ciliogenesis | Q33340686 | ||
Wnt signalling: pathway or network? | Q33712586 | ||
Formation of extra centrosomal structures is dependent on β-catenin | Q34098448 | ||
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. | Q34575151 | ||
Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer | Q34771185 | ||
The Nek2 protein kinase: a novel regulator of centrosome structure | Q34818240 | ||
The Wnt signalling pathway | Q34925309 | ||
Adenomatous polyposis coli and EB1 localize in close proximity of the mother centriole and EB1 is a functional component of centrosomes. | Q36012450 | ||
T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin | Q36333561 | ||
Structure and duplication of the centrosome | Q36860079 | ||
Gamma-tubulin-containing abnormal centrioles are induced by insufficient Plk4 in human HCT116 colorectal cancer cells | Q37295489 | ||
Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation | Q39724881 | ||
A central role for CK1 in catalyzing phosphorylation of the p53 transactivation domain at serine 20 after HHV-6B viral infection. | Q39955472 | ||
A novel role of phospho-beta-catenin in microtubule regrowth at centrosome | Q40177769 | ||
Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination | Q40366558 | ||
Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma | Q40385782 | ||
Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle | Q40595314 | ||
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. | Q40641191 | ||
Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases. | Q40821409 | ||
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. | Q40967633 | ||
Inhibition of glycogen synthase kinase 3 beta attenuates neurocognitive dysfunction resulting from cranial irradiation. | Q42439018 | ||
PCM1 Recruits Plk1 to Pericentriolar Matrix to Promote Primary Cilia Disassembly before Mitotic Entry | Q42826397 | ||
Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. | Q43109940 | ||
Regulation of beta-catenin structure and activity by tyrosine phosphorylation. | Q43560193 | ||
Using deubiquitylating enzymes as research tools | Q46794679 | ||
Phosphorylated β-catenin localizes to centrosomes of neuronal progenitors and is required for cell polarity and neurogenesis in developing midbrain | Q49078794 | ||
Nek2 expression and localization in porcine oocyte during maturation. | Q50719523 | ||
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. | Q52537297 | ||
Plk1 controls the Nek2A-PP1γ antagonism in centrosome disjunction. | Q54577402 | ||
Structural and chemical characterization of isolated centrosomes | Q69466305 | ||
Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin | Q73735409 | ||
Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells | Q74130209 | ||
Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors | Q78760398 | ||
The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1 | Q79754843 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | 977-991 | |
P577 | publication date | 2014-02-05 | |
P1433 | published in | Molecular Biology of the Cell | Q2338259 |
P1476 | title | Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1. | |
P478 | volume | 25 |
Q64270466 | Activation of Epithelial-Mesenchymal Transition and Altered β-Catenin Signaling in a Novel Indian Colorectal Carcinoma Cell Line |
Q64111632 | CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin |
Q26785528 | Connections between cadherin-catenin proteins, spindle misorientation, and cancer |
Q36289531 | Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer |
Q37200065 | Dishevelled is a NEK2 kinase substrate controlling dynamics of centrosomal linker proteins |
Q90421769 | Highlight article: Role of E2Fs and mitotic regulators controlled by E2Fs in the epithelial to mesenchymal transition |
Q64282259 | Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors |
Q92099394 | Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer |
Q64971000 | Mechanistic Insights into Colorectal Cancer Phenomics from Fundamental and Organotypic Model Studies. |
Q46237762 | Mitotic Regulation by NEK Kinase Networks |
Q49919956 | Multiple oncogenic roles of nuclear beta-catenin. |
Q91792599 | NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B/H3K4me3 |
Q33598631 | NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation |
Q34609883 | Nek2 is a novel regulator of B cell development and immunological response |
Q64937133 | Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin. |
Q28081713 | New frontiers: discovering cilia-independent functions of cilia proteins |
Q44052835 | Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival |
Q52352270 | PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells |
Q48134269 | Phosphorylated Tyr142 β-catenin localizes to centrosomes and is regulated by Syk. |
Q41812307 | Quantifying β-catenin subcellular dynamics and cyclin D1 mRNA transcription during Wnt signaling in single living cells. |
Q36637143 | RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer |
Q35090475 | Role of NEK2A in human cancer and its therapeutic potentials. |
Q48821774 | SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. |
Q36956969 | Targeting NEK2 as a promising therapeutic approach for cancer treatment |
Q99728115 | The Greatwall kinase safeguards the genome integrity by affecting the kinome activity in mitosis |
Q39457168 | The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? |
Q41074649 | WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death |
Q38908764 | WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited |
Search more.